Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

FDA cleared the device for use in adults with type 2 diabetes in August. Perspective from Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP Adults with insulin-treated type 2 diabetes ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use ... 2, NovoPen ® 1.5 and NovoPen ® 3) in the diabetes ...

The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

Sulphonylureas and the glinides sensitize pancreatic β-cells to produce insulin. Both also cause ... adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 27, 17–20 ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...

Getting to know what’s going on in your body can help you manage type 2 diabetes well. It’s a chronic condition in which your body doesn’t use insulin properly. This causes sugar to build up ...